20 Slash 20 Inc., the innovator behind The Eye Drink, has been featured in coverage of the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference. The company, which describes The Eye Drink as the world's first clinically inspired, ready-to-drink functional beverage for eye health, is drawing attention for its unique approach to addressing the challenges of modern screen usage.
The Eye Drink is specifically formulated to minimize ocular issues in today's screen-heavy world. Designed for individuals who spend long hours daily staring at computer or cellphone screens, the beverage aims to reduce screen-induced dry eyes and macular damage. The formula incorporates science-backed nutrients based on AREDS 2 Studies, along with vegan-friendly triglyceride-formed Omega-3, to protect visual performance and improve ocular comfort.
This development is significant as it represents a convergence of clinical research and consumer convenience. By transforming clinical science into a simple, delicious, and enjoyable daily habit, 20Slash20 is modernizing preventive eyecare. The product is available through direct-to-consumer channels, professional medical affiliates, and natural product retail stores, making it accessible to a broad audience.
The company's participation in the conference, organized by Moody Capital Solutions Inc., highlights the growing interest in functional beverages that address specific health concerns. Moody Capital, an independent full-service investment bank with over 40 years of experience in capital raising, M&A, and advisory services, is recognized as a market leader in rights offerings and is a member of FINRA/SIPC. The conference serves as a platform for disruptive growth companies to present their innovations to investors and industry stakeholders.
IBN, a multifaceted financial news and publishing company, is providing comprehensive coverage of the event. IBN's custom-built portal includes summaries on each participating company, enabling proficient evaluation through one-click access to market research tools and helpful website links. By leveraging social media and syndicated articles, IBN maximizes the visibility of the event and the companies involved.
For more than a decade, IBN has delivered real-time coverage for numerous global events and conferences through its various brands and investment newsletters. This year, IBN's syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily, ensuring that innovative companies like 20Slash20 gain the exposure they deserve.
The potential impact of The Eye Drink extends beyond individual consumers. As remote work and digital device usage continue to rise, eye health has become a pressing public health concern. By offering a preventive solution rooted in clinical evidence, 20Slash20 is addressing a need that affects a significant portion of the population. The company's approach could influence other players in the beverage industry to consider health-specific formulations, potentially spurring further innovation.
For those interested in learning more about The Eye Drink or attending future events, more information is available at the company's website at theeyedrink.com. Details about the conference and IBN's coverage can be accessed at moodycapital.com/conference and ibn.fm/MoodyCapital2026Conference.
